PSP Research LLC
Filing Date
Global Rank
#7,286
/ 8,605
▼ 168
· as of Mar 2026
Top Industry
Biotechnology
79.5%
3Y Alpha vs SPY
+78.1%
Period ended 3 months ago
Filed Apr 17, 2026 · 3mo
2 quarters · since Dec 2025
Clone Performance
Feb 2026–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+36.5%
SPY
+10.0%
Annualised alpha
+91.7%
Max drawdown
−7.6%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
77 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
14.1%
+12.8 pts
Top 5
21.1%
+14.5 pts
Top 10
28.7%
+15.9 pts
HHI
307
Diversified+186
Portfolio Trend
2 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $34,477,431 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
10 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | +984 | 19,700 | $464,132 | |
| IMCR | Immunocore Holdings plc | +717 | 15,141 | $456,501 | |
| INBX | Inhibrx Biosciences, Inc. | +538 | 6,927 | $465,702 | |
| TARS | Tarsus Pharmaceuticals, Inc. | +481 | 7,000 | $491,050 | |
| VKTX | Viking Therapeutics, Inc. | +286 | 15,000 | $488,100 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | +147 | 1,465 | $484,724 | |
| NBIX | Neurocrine Biosciences Inc | +114 | 3,848 | $506,935 | |
| NAMS | NewAmsterdam Pharma Co N.V. | +80 | 15,000 | $480,150 | |
| ARGX | Argenx SE | +11 | 641 | $468,090 | |
| VERA | Vera Therapeutics, Inc. | +4 | 10,000 | $402,300 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | −33,385 | 10,838 | $150,648 | |
| OCUL | Ocular Therapeutix, Inc | −27,853 | 15,000 | $127,050 | |
| EYPT | EyePoint, Inc. | −19,530 | 10,000 | $128,900 | |
| ALKS | Alkermes plc. | −13,280 | 6,000 | $212,160 | |
| LEGN | Legend Biotech Corp | −12,397 | 12,000 | $217,080 | |
| SYRE | Spyre Therapeutics, Inc. | −10,681 | 5,159 | $260,219 | |
| ZYME | Zymeworks Inc. | −10,312 | 10,000 | $250,400 | |
| KOD | Kodiak Sciences Inc. | −9,418 | 10,000 | $381,200 | |
| OLMA | Olema Pharmaceuticals, Inc. | −9,063 | 10,000 | $149,100 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −7,725 | 5,000 | $419,600 | |
| XENE | Xenon Pharmaceuticals Inc. | −7,478 | 4,200 | $244,230 | |
| CLDX | Celldex Therapeutics, Inc. | −7,368 | 13,000 | $412,360 | |
| TYRA | Tyra Biosciences, Inc. | −5,853 | 16,000 | $612,800 | |
| IMNM | Immunome Inc. | −5,245 | 20,000 | $437,400 | |
| TGTX | Tg Therapeutics, Inc. | −4,807 | 13,000 | $431,860 | |
| SUPN | Supernus Pharmaceuticals, Inc. | −4,758 | 6,000 | $310,140 | |
| SNDX | Syndax Pharmaceuticals Inc | −4,716 | 20,000 | $467,200 | |
| STOK | Stoke Therapeutics, Inc. | −4,621 | 12,000 | $390,720 | |
| APGE | Apogee Therapeutics, Inc. | −4,484 | 2,500 | $210,425 | |
| AUPH | Aurinia Pharmaceuticals Inc. | −3,953 | 30,000 | $444,600 | |
| KNSA | Kiniksa Pharmaceuticals International, plc | −3,655 | 9,000 | $433,350 | |
| RAPP | Rapport Therapeutics, Inc. | −3,506 | 14,000 | $438,060 | |
| CELC | Celcuity Inc. | −3,244 | 2,000 | $228,280 | |
| PTGX | Protagonist Therapeutics, Inc | −3,121 | 3,000 | $316,200 | |
| RPRX | Royalty Pharma plc | −2,826 | 11,000 | $527,670 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
20 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SERA | Sera Prognostics, Inc. | 2,396,685 | $4,865,270 | |
| DFTX | Definium Therapeutics, Inc. | 34,800 | $657,720 | |
| IRON | Disc Medicine, Inc. | 8,000 | $511,520 | |
| AGIO | Agios Pharmaceuticals, Inc. | 15,000 | $507,450 | |
| AXSM | Axsome Therapeutics, Inc. | 2,845 | $480,861 | |
| ARDX | Ardelyx, Inc. | 80,000 | $479,200 | |
| RARE | Ultragenyx Pharmaceutical Inc. | 22,100 | $462,995 | |
| GLUE | Monte Rosa Therapeutics, Inc. | 28,000 | $460,600 | |
| CMPS | COMPASS Pathways plc | 71,000 | $392,630 | |
| TRVI | Trevi Therapeutics, Inc. | 30,000 | $357,900 | |
| NTLA | Intellia Therapeutics, Inc. | 26,900 | $344,858 | |
| TNGX | Tango Therapeutics, Inc. | 14,400 | $301,248 | |
| ERAS | Erasca, Inc. | 17,327 | $280,350 | |
| ELVN | Enliven Therapeutics, Inc. | 7,000 | $274,400 | |
| ORKA | Oruka Therapeutics, Inc. | 4,968 | $243,680 | |
| KALV | KalVista Pharmaceuticals, Inc. | 10,795 | $217,303 | |
| EWTX | Edgewise Therapeutics, Inc. | 6,500 | $204,750 | |
| SMMT | Summit Therapeutics Inc. | 10,223 | $193,828 | |
| ORIC | Oric Pharmaceuticals, Inc. | 13,000 | $164,710 | |
| CMPX | Compass Therapeutics, Inc. | 30,000 | $158,700 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | 15,272 | $583,543 | |
| JAZZ | Jazz Pharmaceuticals plc | 3,258 | $553,860 | |
| CGON | CG Oncology, Inc. | 13,293 | $551,925 | |
| BLTE | Belite Bio, Inc | 3,443 | $550,742 | |
| APLS | Apellis Pharmaceuticals, Inc. | 21,866 | $549,273 | |
| TERN | Terns Pharmaceuticals, Inc. | 13,560 | $547,824 | |
| RVMD | Revolution Medicines, Inc. | 6,872 | $547,354 | |
| CNTA | Centessa Pharmaceuticals plc | 21,879 | $547,193 | |
| MLYS | Mineralys Therapeutics, Inc. | 14,818 | $537,745 | |
| ACLX | Arcellx, Inc. | 8,224 | $536,204 | |
| ROIV | Roivant Sciences Ltd. | 24,621 | $534,275 | |
| LQDA | Liquidia Corp | 15,485 | $534,077 | |
| PVLA | Palvella Therapeutics, Inc. | 5,084 | $532,142 | |
| INSM | INSMED Inc | 3,049 | $530,647 | |
| NUVL | Nuvalent, Inc. | 5,261 | $529,203 | |
| VRDN | Viridian Therapeutics, Inc.DE | 16,967 | $528,013 | |
| WVE | Wave Life Sciences Ltd. | 31,040 | $527,680 | |
| MAZE | Maze Therapeutics, Inc. | 12,672 | $525,000 | |
| DNLI | Denali Therapeutics Inc. | 31,762 | $524,390 | |
| BMRN | Biomarin Pharmaceutical Inc | 8,772 | $521,319 | |
| BEAM | Beam Therapeutics Inc. | 18,334 | $508,218 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 4,738 | $507,155 | |
| UPB | Upstream Bio, Inc. | 17,634 | $478,763 | |
| GPCR | Structure Therapeutics Inc. | 6,719 | $467,306 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 6,689 | $444,082 | |
| No positions match the current search. | ||||
77 positions ·
$34,477,431 total
· as of Mar 31, 2026
Showing 1–50
of 77 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SERA |
Sera Prognostics, Inc.
Healthcare
|
NEW | 2,396,685 | $4,865,270 | 14.11% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
NEW | 34,800 | $657,720 | 1.91% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Reduced | 16,000 | $612,800 | 1.78% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Reduced | 2,500 | $571,825 | 1.66% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Reduced | 20,000 | $565,000 | 1.64% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 8,300 | $547,053 | 1.59% | |
| RPRX |
Royalty Pharma plc
Healthcare
|
Reduced | 11,000 | $527,670 | 1.53% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Reduced | 6,300 | $524,727 | 1.52% | |
| HALO |
Halozyme Therapeutics, Inc.
Healthcare
|
Held | 8,026 | $518,720 | 1.50% | |
| EXEL |
Exelixis, Inc.
Healthcare
|
Held | 11,948 | $512,449 | 1.49% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
NEW | 8,000 | $511,520 | 1.48% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Held | 6,800 | $510,612 | 1.48% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
NEW | 15,000 | $507,450 | 1.47% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Added | 3,848 | $506,935 | 1.47% | |
| INCY |
Incyte Corp
Healthcare
|
Reduced | 5,300 | $498,836 | 1.45% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Added | 7,000 | $491,050 | 1.42% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
Added | 15,000 | $488,100 | 1.42% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Added | 1,465 | $484,724 | 1.41% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 1,500 | $483,285 | 1.40% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
NEW | 2,845 | $480,861 | 1.39% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Added | 15,000 | $480,150 | 1.39% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
NEW | 80,000 | $479,200 | 1.39% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Reduced | 19,200 | $476,928 | 1.38% | |
| ARGX |
Argenx SE
Healthcare
|
Added | 641 | $468,090 | 1.36% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 20,000 | $467,200 | 1.36% | |
| INBX |
Inhibrx Biosciences, Inc.
Healthcare
|
Added | 6,927 | $465,702 | 1.35% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
Added | 19,700 | $464,132 | 1.35% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
NEW | 22,100 | $462,995 | 1.34% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Reduced | 5,000 | $461,900 | 1.34% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 12,000 | $461,880 | 1.34% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
NEW | 28,000 | $460,600 | 1.34% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Added | 15,141 | $456,501 | 1.32% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
Reduced | 9,500 | $451,915 | 1.31% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 6,000 | $445,560 | 1.29% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Reduced | 28,700 | $444,850 | 1.29% | |
| AUPH |
Aurinia Pharmaceuticals Inc.
Healthcare
|
Reduced | 30,000 | $444,600 | 1.29% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Held | 19,766 | $439,991 | 1.28% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Reduced | 14,000 | $438,060 | 1.27% | |
| IMNM |
Immunome Inc.
Healthcare
|
Reduced | 20,000 | $437,400 | 1.27% | |
| KNSA |
Kiniksa Pharmaceuticals International, plc
Healthcare
|
Reduced | 9,000 | $433,350 | 1.26% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
Reduced | 13,000 | $431,860 | 1.25% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 5,000 | $419,600 | 1.22% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 13,000 | $412,360 | 1.20% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Reduced | 6,000 | $408,780 | 1.19% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Added | 10,000 | $402,300 | 1.17% | |
| HRMY |
Harmony Biosciences Holdings, Inc.
Healthcare
|
Held | 14,283 | $400,066 | 1.16% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Reduced | 11,000 | $399,520 | 1.16% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
NEW | 71,000 | $392,630 | 1.14% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Reduced | 12,000 | $390,720 | 1.13% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Reduced | 10,000 | $381,200 | 1.11% |